Jones Financial Companies
RCUS icon

Jones Financial Companies’s Arcus Biosciences RCUS Stock Holding History

Jones Financial Companies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08K Hold
67
– – ﹤0.01% 4413
2026
Q1 		$1.36K Hold
67
– – ﹤0.01% 4265
2025
Q4 		$1.6K Hold
67
– – ﹤0.01% 3888
2025
Q3 		$860 Hold
67
– – ﹤0.01% 3933
2025
Q2 		$533 Buy
+67
New +$572 ﹤0.01% 3794

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jones Financial Companies's RCUS Position: Q2 2026 in Review

Jones Financial Companies held its Arcus Biosciences (RCUS) position steady in Q2 2026 at 67 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #4413.

Jones Financial Companies first reported a position in RCUS in Q2 2025 and has held it in 5 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Jones Financial Companies held 67 shares of Arcus Biosciences worth $2.08K as of Q2 2026.
  • Jones Financial Companies left its Arcus Biosciences share count unchanged in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4413 holding.
  • Jones Financial Companies first reported a position in Arcus Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.